Guidelines version available to download
Table of contents: Full Text (ESC Clinical Practice Guidelines)
- Preamble
- Introduction
- Evidence review
- Relationship with industry and other conflicts of interest
- What is new in the 2019 Guidelines?
- Definition and lcassification
- Electrophysiological mechanisms of supraventricular tachycardia
- Cardiac anatomy for the electrophysiologist
- Epidemiology of supraventricular tachycardia
- Clinical presentation
- Initial evaluation of patients with supraventrcular tachycardia
- Differential diagnosis of tachycardia
- Narrow QRS (=120ms) tachycardia
- Electrocardiographic differential diagnosis
- Vagal manoeuvres and adenosine
- Electrophysiology study
- Wide QRS (>120ms) tachycardia
- Electrocardiographic differential diagnosis
- Electrophysiology study
- Irregular tachycardia
- Narrow QRS (=120ms) tachycardia
- Specific types of supraventricular tachycardia
- Atrial arrhythmias
- Sinus tachydardia
- Focal atrial tachycardia
- Multifocal atrial tachycardia
- Maro-re-entrant atrial tachycardia
- Atrioventricular junctional arrhythmias
- Atrialventricular modal re-entrant tachycardia
- Non-re-entrant junctional tachycardia
- Atrioventricular arrhythmia
- Accessory pathways
- Wolff Parkinson White syndrome
- Orthodromic atrioventricular re-entrant tachycardia
- Antidromic atrioventricular re-entrant tachycardia
- Accessory pathway as a bystander
- Pre-excited atrial fibrillation
- Concealed accessory pathways
- Permanent junctional reciprocating tachycardia
- Atypical forms of pre-excitation (Mahaim fibres)
- Atrial arrhythmias
- Supraventricular tachycardia in adults with congenital heart disease
- Pharmacopological antiarrhythmic therapy
- Catheter and surgical ablation
- Specific disease states
- Atrial septal defect
- Ebstein's anomaly
- Transposition of the great arteries
- Tetralogy of Fallot
- Fontan repairs
- Supraventricular tacycardia in the paediatric population
- Foetal arrhythmias
- Supraventricular tachycardia in pregnancy
- Material obstretic and offspring risk
- Therapy
- Antiarrhythmic drugs
- Electrical cardioversion
- Catheter ablation
- Tachycardia-induced cardiomyopathy
- Definition
- Mechanism
- Diagnosis
- Therapy
- Supraventricular tachycardia in sports
- Supraventricular tachycardia and driving restrictions
- Key messages
- Gaps in evidence
- Evidence-based "what to do" and 'what not to do" messages from the Guidelines
- Supplementary data
- Appendix
- References
Previous version available to download
Our mission: To reduce the burden of cardiovascular disease.